Dynamics and Establishment of Clostridium difficile Infection in the Murine Gastrointestinal Tract

ABSTRACT Clostridium difficile infection (CDI) following antibiotic therapy is a major public health threat. While antibiotic disruption of the indigenous microbiota underlies the majority of cases of CDI, the early dynamics of infection in the disturbed intestinal ecosystem are poorly characterized. This study defines the dynamics of infection with C. difficile strain VPI 10463 throughout the gastrointestinal (GI) tract using a murine model of infection. After inducing susceptibility to C. difficile colonization via antibiotic administration, we followed the dynamics of spore germination, colonization, sporulation, toxin activity, and disease progression throughout the GI tract. C. difficile spores were able to germinate within 6 h postchallenge, resulting in the establishment of vegetative bacteria in the distal GI tract. Spores and cytotoxin activity were detected by 24 h postchallenge, and histopathologic colitis developed by 30 h. Within 36 h, all infected mice succumbed to infection. We correlated the establishment of infection with changes in the microbiota and bile acid profile of the small and large intestines. Antibiotic administration resulted in significant changes to the microbiota in the small and large intestines, as well as a significant shift in the abundance of primary and secondary bile acids. Ex vivo analysis suggested the small intestine as the site of spore germination. This study provides an integrated understanding of the timing and location of the events surrounding C. difficile colonization and identifies potential targets for the development of new therapeutic strategies.

[1]  J. Bartlett,et al.  Clindamycin-associated colitis due to a toxin-producing species of Clostridium in hamsters. , 1977, The Journal of infectious diseases.

[2]  K. Wilson,et al.  Population dynamics of ingested Clostridium difficile in the gastrointestinal tract of the Syrian hamster. , 1985, The Journal of infectious diseases.

[3]  Dae-Joong Kang,et al.  Bile salt biotransformations by human intestinal bacteria Published, JLR Papers in Press, November 18, 2005. , 2006, Journal of Lipid Research.

[4]  W. Ludwig,et al.  SILVA: a comprehensive online resource for quality checked and aligned ribosomal RNA sequence data compatible with ARB , 2007, Nucleic acids research.

[5]  A. Sonenshein,et al.  Bile Salts and Glycine as Cogerminants for Clostridium difficile Spores , 2008, Journal of bacteriology.

[6]  A. Sonenshein,et al.  Chenodeoxycholate Is an Inhibitor of Clostridium difficile Spore Germination , 2008, Journal of bacteriology.

[7]  R. Lewis,et al.  Characterization of the Sporulation Initiation Pathway of Clostridium difficile and Its Role in Toxin Production , 2009, Journal of bacteriology.

[8]  Martin Hartmann,et al.  Introducing mothur: Open-Source, Platform-Independent, Community-Supported Software for Describing and Comparing Microbial Communities , 2009, Applied and Environmental Microbiology.

[9]  Mark H. Wilcox,et al.  Clostridium difficile infection: new developments in epidemiology and pathogenesis , 2009, Nature Reviews Microbiology.

[10]  James R. Cole,et al.  The Ribosomal Database Project: improved alignments and new tools for rRNA analysis , 2008, Nucleic Acids Res..

[11]  J. L. Giel,et al.  Metabolism of Bile Salts in Mice Influences Spore Germination in Clostridium difficile , 2010, PloS one.

[12]  Rob Knight,et al.  UCHIME improves sensitivity and speed of chimera detection , 2011, Bioinform..

[13]  Amber Howerton,et al.  Mapping Interactions between Germinants and Clostridium difficile Spores , 2010, Journal of bacteriology.

[14]  D. Aronoff,et al.  Cefoperazone-treated mice as an experimental platform to assess differential virulence of Clostridium difficile strains , 2011, Gut microbes.

[15]  Patrick D Schloss,et al.  The interplay between microbiome dynamics and pathogen dynamics in a murine model of Clostridium difficile Infection , 2011, Gut microbes.

[16]  A. Viale,et al.  Profound Alterations of Intestinal Microbiota following a Single Dose of Clindamycin Results in Sustained Susceptibility to Clostridium difficile-Induced Colitis , 2011, Infection and Immunity.

[17]  S. Sattar,et al.  Clospore: a liquid medium for producing high titers of semi-purified spores of Clostridium difficile. , 2011, Journal of AOAC International.

[18]  R. Britton,et al.  Interaction between the intestinal microbiota and host in Clostridium difficile colonization resistance. , 2012, Trends in microbiology.

[19]  Margaret A. Olsen,et al.  Burden of Clostridium difficile on the Healthcare System , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  Vincent B. Young,et al.  Suppression of Clostridium difficile in the Gastrointestinal Tracts of Germfree Mice Inoculated with a Murine Isolate from the Family Lachnospiraceae , 2012, Infection and Immunity.

[21]  M. Wilcox,et al.  Models for the study of Clostridium difficile infection , 2012, Gut microbes.

[22]  F. Bäckhed,et al.  Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. , 2013, Cell metabolism.

[23]  J. Rood,et al.  Spo0A Differentially Regulates Toxin Production in Evolutionarily Diverse Strains of Clostridium difficile , 2013, PloS one.

[24]  B. Weimer,et al.  Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens , 2013, Nature.

[25]  V. Young,et al.  Murine models to study Clostridium difficile infection and transmission. , 2013, Anaerobe.

[26]  Sarah L. Westcott,et al.  Development of a Dual-Index Sequencing Strategy and Curation Pipeline for Analyzing Amplicon Sequence Data on the MiSeq Illumina Sequencing Platform , 2013, Applied and Environmental Microbiology.

[27]  C. Buffie,et al.  Microbiota-mediated colonization resistance against intestinal pathogens , 2013, Nature Reviews Immunology.

[28]  Joseph A. Sorg Microbial bile acid metabolic clusters: the bouncers at the bar. , 2014, Cell host & microbe.

[29]  D. Paredes-Sabja,et al.  Clostridium difficile spore biology: sporulation, germination, and spore structural proteins. , 2014, Trends in microbiology.

[30]  M. Monot,et al.  The Flagellin FliC of Clostridium difficile Is Responsible for Pleiotropic Gene Regulation during In Vivo Infection , 2014, PloS one.

[31]  Bo Li,et al.  Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection , 2014, Nature Communications.

[32]  B. B. Finlay,et al.  Gastrointestinal microbiota-mediated control of enteric pathogens. , 2014, Annual review of genetics.

[33]  A. Sonenshein,et al.  Integration of metabolism and virulence in Clostridium difficile. , 2015, Research in Microbiology.